Pharmaceutical composition of Anti-CD20 antibody and use thereof.

TN2025000018A1Undetermined Publication Date: 2026-10-01JOINT CO BIOCAD

0 Cites 0 Cited by

Patent Information

Application Number: TN2025000018P0
Authority / Receiving Office: TN · TN
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-01-23
Publication Date: 2026-10-01

Application Information

Patent Timeline

23 Jan 2025

Application

TN2025000018P0

01 Oct 2026

Publication

TN2025000018A1

Inventors: IAKOVLEV, Aleksandr Olegovich; LOMKOVA, Ekaterina Aleksandrovna

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to the field of pharmacy and medicine, specifically to pharmaceutical compositions of anti-CD20 antibody, in particular divozilimab, which compositions may be used to treat a CD20mediated disease or disorder. The invention further relates to the use of said compositions for the treatment of a CD20-mediated disease or disorder, as well as to a method of treating a CD20-mediated disease or disorder, comprising administering said compositions.

Need to check novelty before this filing date? Find Prior Art